<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="g6pc3-def" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">g6pc3-def</book-part-id>
      <title-group>
        <title>G6PC3 Deficiency</title>
        <alt-title alt-title-type="alt-title">Synonym: Ubiquitous Glucose-6-Phosphatase Deficiency</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Banka</surname>
            <given-names>Siddharth</given-names>
          </name>
          <degrees>MD, MRCPCH, PhD</degrees>
          <aff>Manchester Centre for Genomic Medicine - Institute of Human Development<break/>Faculty of Medical and Human Sciences<break/>University of Manchester<break/>Manchester Centre for Genomic Medicine - Saint Mary&#x02019;s Hospital<break/>Central Manchester University Hospitals NHS Foundation Trust<break/>Manchester Academic Health Science Centre<break/>Manchester, United Kingdom</aff>
          <email>siddharth.banka@manchester.ac.uk</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>16</day>
          <month>4</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="fum" document-type="chapter">Fumarate Hydratase Deficiency</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="cmt2d" document-type="chapter"><italic toggle="yes">GARS</italic>-Associated Axonal Neuropathy</related-object>
      <abstract id="g6pc3-def.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>G6PC3 deficiency is characterized by severe congenital neutropenia which occurs in a phenotypic continuum that includes the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Isolated severe congenital neutropenia (nonsyndromic)</p>
            </list-item>
            <list-item>
              <p>Classic G6PC3 deficiency (severe congenital neutropenia plus cardiovascular and/or urogenital abnormalities)</p>
            </list-item>
            <list-item>
              <p>Severe G6PC3 deficiency (classic G6PC3 deficiency plus involvement of non-myeloid hematopoietic cell lines, additional extra-hematologic features, and pulmonary hypertension; known as Dursun syndrome)</p>
            </list-item>
          </list>
          <p>Neutropenia usually presents with recurrent bacterial infections in the first few months of life. Intrauterine growth restriction (IUGR), failure to thrive (FTT), and poor postnatal growth are common. Other findings in classic and severe G6PC3 deficiency can include inflammatory bowel disease (IBD) resembling Crohn&#x02019;s disease, and endocrine disorders (growth hormone deficiency, hypogonadotropic hypogonadism, and delayed puberty).</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of G6PC3 deficiency is established in a proband with severe congenital neutropenia and biallelic (homozygous or compound heterozygous) <italic toggle="yes">G6PC3</italic> pathogenic variants on molecular genetic testing.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Treatment with granulocyte colony stimulating factor (G-CSF) that maintains absolute neutrophil counts above 0.5x10<sup>9</sup>/L reduces the number of infections and improves the quality of life. A few mildly affected individuals have been reported to be adequately managed with prophylactic antibiotics alone. Fevers and infections require prompt treatment with antibiotics. Routine management of congenital heart disease, renal and urinary tract malformations, and hormone deficiencies as needed.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Good dental hygiene, including careful brushing and flossing and regular visits to the dentist, helps decrease the potential for infection. Prophylactic antibiotics should be considered in those with uncorrected neutropenia undergoing dental procedures, especially in those with heart defects at increased risk for subacute bacterial endocarditis.</p>
          <p><italic toggle="yes">Surveillance:</italic> Frequent follow up by a hematologist or immunologist to monitor infection frequency and neutrophil counts to ensure an adequate response to G-CSF. Monitor growth in children, pubertal development in adolescents, and development of varicose veins, especially in adults. Monitoring for osteopenia/osteoporosis.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> It is appropriate to evaluate the older and younger sibs of a proband in order to identify as early as possible those who would benefit from early diagnosis and management of the hematologic, cardiac, renal, and endocrine abnormalities of G6PC3 deficiency. The genetic status of at-risk sibs can be clarified by molecular genetic testing (if the <italic toggle="yes">G6PC3</italic> pathogenic variants in the family are known) or by clinical findings.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>G6PC3 deficiency is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the <italic toggle="yes">G6PC3</italic> pathogenic variants have been identified in the family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="g6pc3-def.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="g6pc3-def.Tc" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_g6pc3-def.Tc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">G6PC3 Deficiency: Included Phenotypes</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_g6pc3-def.Tc_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Nonsyndromic severe congenital neutropenia due to G6PC3 deficiency</p></list-item><list-item><p>Classic G6PC3 deficiency (severe congenital neutropenia type 4)</p></list-item><list-item><p>Severe G6PC3 deficiency (Dursun syndrome)</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="g6pc3-def.Diagnosis">
        <title>Diagnosis</title>
        <p>Consensus diagnostic criteria for G6PC3 deficiency have not been established.</p>
        <sec id="g6pc3-def.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>G6PC3 deficiency should be suspected in individuals with the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Severe congenital neutropenia defined as an absolute neutrophil count &#x0003c;0.5 x 10<sup>9</sup>/L which usually results in early-onset, frequent, severe bacterial infections</p>
              <p>Note: Although maturation arrest of myeloid cells was initially thought to be the typical finding on bone marrow examination [<xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2009.32">Boztug et al 2009</xref>], subsequent reports identified bone marrows that were hypercellular [<xref ref-type="bibr" rid="g6pc3-def.REF.mcdermott.2010.2793">McDermott et al 2010</xref>] and normocellular [<xref ref-type="bibr" rid="g6pc3-def.REF.banka.2011b.235">Banka et al 2011b</xref>]. More recently, sequential bone marrow examinations have typically revealed normal maturation and only rarely arrested maturation [<xref ref-type="bibr" rid="g6pc3-def.REF.desplantes.2014.183">Desplantes et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p>A family history consistent with autosomal recessive inheritance [<xref ref-type="bibr" rid="g6pc3-def.REF.banka.2013.84">Banka &#x00026; Newman 2013</xref>]</p>
            </list-item>
          </list>
          <p>To date all individuals with G6PC3 deficiency have had severe congenital neutropenia; the phenotypic spectrum is a continuum that ranges from nonsyndromic (isolated severe congenital neutropenia) to classic (severe congenital neutropenia plus cardiovascular and/or urogenital abnormalities) to severe (classic G6PC3 deficiency plus involvement of non-myeloid hematopoietic cell lines and additional extra-hematologic features).</p>
          <p><bold>Nonsyndromic G6PC3 deficiency</bold> includes only hematologic findings &#x02013;predominantly severe congenital neutropenia [<xref ref-type="bibr" rid="g6pc3-def.REF.smith.2012.146">Smith et al 2012</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.banka.2013.138">Banka et al 2013</xref>].</p>
          <p><bold>Classic G6PC3 deficiency</bold> (known as severe congenital neutropenia type 4) includes severe congenital neutropenia as well as additional features [<xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2009.32">Boztug et al 2009</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.banka.2011a.18">Banka et al 2011a</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2012.679">Boztug et al 2012</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Other hematologic abnormalities: intermittent thrombocytopenia (66%)</p>
            </list-item>
            <list-item>
              <p>Cardiovascular defects</p>
              <list list-type="bullet">
                <list-item>
                  <p>Congenital heart defects (~77%) (see <xref ref-type="sec" rid="g6pc3-def.Clinical_Description">Clinical Description</xref>)</p>
                </list-item>
                <list-item>
                  <p>Prominent superficial venous pattern (66%) which may not be visible at birth but tends to gradually develop with age</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Urogenital defects (44%), especially in males in whom cryptorchidism is the most common anomaly</p>
            </list-item>
          </list>
          <p><bold>Severe G6PC3</bold>
<bold>deficiency</bold> (Dursun syndrome) comprises the findings of classic G6PC3 deficiency as well as additional features:</p>
          <list list-type="bullet">
            <list-item>
              <p>Primary pulmonary hypertension (PPH) developing in the newborn period</p>
            </list-item>
            <list-item>
              <p>Non-myeloid cell involvement: severe lymphopenia</p>
            </list-item>
            <list-item>
              <p>Thymic hypoplasia</p>
            </list-item>
          </list>
        </sec>
        <sec id="g6pc3-def.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of G6PC3 deficiency is established in a proband with severe congenital neutropenia and identification of biallelic (homozygous or compound heterozygous) <italic toggle="yes">G6PC3</italic> pathogenic variants on molecular genetic testing (see <xref ref-type="table" rid="g6pc3-def.T.summary_of_molecular_genetic">Table 1</xref>). Molecular testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive genomic testing</bold>:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">G6PC3</italic> followed by consideration of deletion/duplication analysis if only one or no pathogenic variant is found. It should be noted that to date no exon or whole-gene deletions/duplications have been reported.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">G6PC3</italic> and other genes of interest (see <xref ref-type="sec" rid="g6pc3-def.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included and sensitivity of multi-gene panels vary by laboratory and over time.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing, genome sequencing, and mitochondrial sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel) fails to confirm a diagnosis in an individual with features of G6PC3 deficiency. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="g6pc3-def.T.summary_of_molecular_genetic" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in G6PC3 Deficiency</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_g6pc3-def.T.summary_of_molecular_genetic_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_g6pc3-def.T.summary_of_molecular_genetic_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_g6pc3-def.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_g6pc3-def.T.summary_of_molecular_genetic_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">G6PC3</italic>
                  </td>
                  <td headers="hd_h_g6pc3-def.T.summary_of_molecular_genetic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_g6pc3-def.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">16/31 (43%)&#x000a0;<sup>4,&#x000a0;5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_g6pc3-def.T.summary_of_molecular_genetic_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_g6pc3-def.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">None reported</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="g6pc3-def.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="g6pc3-def" object-id="g6pc3-def.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="g6pc3-def.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="g6pc3-def.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="g6pc3-def.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="g6pc3-def.TF.1.4">
                <label>4. </label>
                <p>An estimate based on a single non-systematic study in which <xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2012.679">Boztug et al [2012]</xref> sequenced <italic toggle="yes">G6PC3</italic> in individuals with syndromic forms of congenital neutropenia.</p>
              </fn>
              <fn id="g6pc3-def.TF.1.5">
                <label>5. </label>
                <p>To date more than 91 individuals with molecularly confirmed G6PC3 deficiency have been reported [<xref ref-type="bibr" rid="g6pc3-def.REF.alangari.2013.1403">Alangari et al 2013</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.banka.2013.84">Banka &#x00026; Newman 2013</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.est_vez.2013.e29">Est&#x000e9;vez et al 2013</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.racek.2013">Racek et al 2013</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.desplantes.2014.183">Desplantes et al 2014</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.kaya.2014.e316">Kaya et al 2014</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.notarangelo.2014.80">Notarangelo et al 2014</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.ozg_l.2014.265">Ozg&#x000fc;l et al 2014</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.tavil.2014.426">Tavil et al 2014</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.yeshayahu.2014.197">Yeshayahu et al 2014</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.arikoglu.2015.79">Arikoglu et al 2015</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.lebel.2015.103">Lebel et al 2015</xref>].</p>
              </fn>
              <fn id="g6pc3-def.TF.1.6">
                <label>6. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="g6pc3-def.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="g6pc3-def.Clinical_Description">
          <title>Clinical Description</title>
          <p>G6PC3 deficiency is highly variable in its severity and associated clinical features. Individuals with &#x02018;nonsyndromic&#x02019; disease have only severe congenital neutropenia. The majority of persons with G6PC3 deficiency have cardiovascular and/or urogenital features (so-called classic G6PC3 deficiency). Of those with classic disease, a subset is more severely affected (so-called Dursun syndrome), because of the additional involvement of myeloid cells, primary pulmonary hypertension developing in the newborn period, and minor dysmorphic features.</p>
          <p>While it is estimated that nearly 10% of G6CP3 deficiency is the nonsyndromic form, this could be an underestimate due to ascertainment bias (i.e., selection of more severe phenotypes for testing of <italic toggle="yes">G6PC3</italic> in previous studies) [<xref ref-type="bibr" rid="g6pc3-def.REF.banka.2013.84">Banka &#x00026; Newman 2013</xref>]. It is also possible that some patients who initially present with the nonsyndromic form may develop features of the classic form in later life [<xref ref-type="bibr" rid="g6pc3-def.REF.notarangelo.2014.80">Notarangelo et al 2014</xref>].</p>
          <p>G6PC3 deficiency usually presents in the first few months of life with recurrent bacterial infections. A range of bacterial infections have been reported [<xref ref-type="bibr" rid="g6pc3-def.REF.desplantes.2014.183">Desplantes et al 2014</xref>]; respiratory tract infections, otitis media, stomatitis, urinary tract infections, pyelonephritis, skin abscesses, cellulitis, and sepsis are particularly common. The first serious infection can occur at any age, ranging from immediately after birth to adulthood.</p>
          <p><bold>Hematologic.</bold> Persistent severe neutropenia is present in all affected individuals and is the core phenotype of the condition.</p>
          <p>Intermittent thrombocytopenia is seen frequently but usually does not cause symptoms.</p>
          <p>Lymphopenia associated with hypoplasia of the thymus can be seen in more severely affected individuals [<xref ref-type="bibr" rid="g6pc3-def.REF.dursun.2009.19">Dursun et al 2009</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.banka.2010.2609">Banka et al 2010</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.ozg_l.2014.265">Ozg&#x000fc;l et al 2014</xref>].</p>
          <p><bold>Cardiovascular.</bold> Congenital heart defects are common. In their recent review, <xref ref-type="bibr" rid="g6pc3-def.REF.banka.2013.84">Banka &#x00026; Newman [2013]</xref> found that 44 (77%) of 57 of individuals with G6PC3 deficiency described in the literature had congenital cardiac defects. By far the most common anomaly was atrial septal defect. Other rare heart anomalies include patent foramen ovale; cor triatriatum; patent ductus arteriosus; critical pulmonary stenosis and hypoplastic left ventricle; mitral valve prolapse, insufficiency, and/ or regurgitation; tricuspid insufficiency; and bicuspid aortic and pulmonary valves.</p>
          <p>A prominent superficial venous pattern begins to emerge between late infancy and early childhood in most affected children [<xref ref-type="bibr" rid="g6pc3-def.REF.banka.2011a.18">Banka et al 2011a</xref>]. This pattern can be seen on the trunk, extremities, and sometimes on the head. Experience with adults is limited but older patients have a tendency to develop varicose veins and venous ulcers.</p>
          <p>In Dursun syndrome early-onset primary pulmonary hypertension can be difficult to control [<xref ref-type="bibr" rid="g6pc3-def.REF.dursun.2009.19">Dursun et al 2009</xref>]. In a few individuals primary pulmonary hypertension may be detected later in life [<xref ref-type="bibr" rid="g6pc3-def.REF.mcdermott.2010.2793">McDermott et al 2010</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.fernandez.2012.111">Fernandez et al 2012</xref>].</p>
          <p><bold>Urogenital anomalies</bold> are more common in males than females [<xref ref-type="bibr" rid="g6pc3-def.REF.banka.2013.84">Banka &#x00026; Newman 2013</xref>]. In males the most common feature is cryptorchidism.</p>
          <p>Hydronephrosis, poor renal cortico-medullary differentiation, small kidneys, and vesico-uretric reflux are observed in some patients. Other features include inguinal hernia, ambiguous genitalia in undervirilized males, and urachal fistula.</p>
          <p><bold>Inflammatory bowel disease (IBD)</bold> resembling Crohn&#x02019;s disease has been described in a few individuals [<xref ref-type="bibr" rid="g6pc3-def.REF.cullinane.2011.2017">Cullinane et al 2011</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.fernandez.2012.111">Fernandez et al 2012</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.smith.2012.146">Smith et al 2012</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.b_gin.2013.520">B&#x000e9;gin et al 2013</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.desplantes.2014.183">Desplantes et al 2014</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.kaya.2014.e316">Kaya et al 2014</xref>]. Treatment that improves neutrophil counts can also help resolve the bowel disease [<xref ref-type="bibr" rid="g6pc3-def.REF.kaya.2014.e316">Kaya et al 2014</xref>].</p>
          <p><bold>Endocrine.</bold> Growth hormone deficiency has been described in two affected individuals [<xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2012.679">Boztug et al 2012</xref>].</p>
          <p>Hypogonadotropic hypogonadism and delayed puberty have been reported in both males and females [<xref ref-type="bibr" rid="g6pc3-def.REF.germeshausen.2010.1207">Germeshausen et al 2010</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.banka.2011a.18">Banka et al 2011a</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2012.679">Boztug et al 2012</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.aytekin.2013.e81">Aytekin et al 2013</xref>]. One male, who had no detectable gonadal structures in the scrotum, inguinal canals, or abdomen, had a low testosterone level (unresponsive to HCG stimulation) and extremely high LH and FSH levels [<xref ref-type="bibr" rid="g6pc3-def.REF.yeshayahu.2014.197">Yeshayahu et al 2014</xref>].</p>
          <p>Hypothyroidism has been reported in three individuals [<xref ref-type="bibr" rid="g6pc3-def.REF.banka.2011a.18">Banka et al 2011a</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.desplantes.2014.183">Desplantes et al 2014</xref>].</p>
          <p><bold>Growth.</bold> Intrauterine growth restriction (IUGR), failure to thrive (FTT), and poor postnatal growth are common. The basis of growth problems is not known. It could be secondary to repeated infections or part of the primary phenotype of G6PC3 deficiency.</p>
          <p>
            <bold>Other findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Minor dysmorphic features in some young children, such as a triangular face, depressed nasal bridge, thick lips, and prognathism [<xref ref-type="bibr" rid="g6pc3-def.REF.dursun.2009.19">Dursun et al 2009</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.banka.2011a.18">Banka et al 2011a</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2012.679">Boztug et al 2012</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.desplantes.2014.183">Desplantes et al 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>Neurodevelopmental involvement:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Mild learning difficulties were initially described in four affected individuals from a single family [<xref ref-type="bibr" rid="g6pc3-def.REF.banka.2011a.18">Banka et al 2011a</xref>], although it was not clear whether the findings were attributable to G6PC3 deficiency.</p>
                </list-item>
                <list-item>
                  <p>Recently a study from the French Neutropenia Registry reported neurodevelopmental difficulties in seven of 14 individuals with pathogenic variants in <italic toggle="yes">G6CP3</italic>. Notably, one was said to have major developmental problems with bilateral atrophy on MRI [<xref ref-type="bibr" rid="g6pc3-def.REF.desplantes.2014.183">Desplantes et al 2014</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Skeletal involvement, such as scoliosis and pectus carinatum [<xref ref-type="bibr" rid="g6pc3-def.REF.dursun.2009.19">Dursun et al 2009</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2012.679">Boztug et al 2012</xref>]</p>
            </list-item>
            <list-item>
              <p>Cutis laxa, described in at least seven patients [<xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2012.679">Boztug et al 2012</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.desplantes.2014.183">Desplantes et al 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>Microcephaly [<xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2009.32">Boztug et al 2009</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.germeshausen.2010.1207">Germeshausen et al 2010</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.mcdermott.2010.2793">McDermott et al 2010</xref>], which could be an effect of overall poor growth</p>
            </list-item>
            <list-item>
              <p>Myopathy:</p>
              <list list-type="bullet">
                <list-item>
                  <p>One patient with a single episode of myositis [<xref ref-type="bibr" rid="g6pc3-def.REF.smith.2012.146">Smith et al 2012</xref>]</p>
                </list-item>
                <list-item>
                  <p>One sib pair with proximal muscle weakness [<xref ref-type="bibr" rid="g6pc3-def.REF.mcdermott.2010.2793">McDermott et al 2010</xref>], one of whom developed at age 2.5 years recurrent episodes of proximal muscle pain and cramps; muscle histology suggested glycogen accumulation.</p>
                </list-item>
                <list-item>
                  <p>Two individuals reported with non-specific myopathy but no clinical details [<xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2009.32">Boztug et al 2009</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.desplantes.2014.183">Desplantes et al 2014</xref>]</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Rarer features</bold> (some of which could be coincidental associations)</p>
          <list list-type="bullet">
            <list-item>
              <p>Myelodysplasia followed by acute myelogeneous leukemia with translocation (18, 21) (with no exposure to G-CSF) reported in one affected individual age 14 years [<xref ref-type="bibr" rid="g6pc3-def.REF.desplantes.2014.183">Desplantes et al 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>Mild to moderate bilateral sensorineural hearing loss which may be asymptomatic and is sometimes only detected on audiometry [<xref ref-type="bibr" rid="g6pc3-def.REF.mcdermott.2010.2793">McDermott et al 2010</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.gatti.2011.138">Gatti et al 2011</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2012.679">Boztug et al 2012</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.desplantes.2014.183">Desplantes et al 2014</xref>]. The age of onset is not clear from the published reports.</p>
            </list-item>
            <list-item>
              <p>Congenital ptosis [<xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2012.679">Boztug et al 2012</xref>]</p>
            </list-item>
            <list-item>
              <p>Cleft palate [<xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2009.32">Boztug et al 2009</xref>] and Pierre Robin sequence [<xref ref-type="bibr" rid="g6pc3-def.REF.desplantes.2014.183">Desplantes et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p>Low HDL serum levels and persistently increased amylase activity described in one individual [<xref ref-type="bibr" rid="g6pc3-def.REF.banka.2011a.18">Banka et al 2011a</xref>]</p>
            </list-item>
          </list>
          <p><bold>Disease course.</bold> When neutropenia is treated (see <xref ref-type="sec" rid="g6pc3-def.Management">Management</xref>), most patients have a good prognosis with reduced rate and severity of infections.</p>
          <p>If neutropenia is untreated, G6PC3 deficiency can lead to death in early childhood from infections [<xref ref-type="bibr" rid="g6pc3-def.REF.alizadeh.2011.227">Alizadeh et al 2011</xref>] or severe respiratory distress [<xref ref-type="bibr" rid="g6pc3-def.REF.dursun.2009.19">Dursun et al 2009</xref>]. One adult who was non-compliant with treatment died at age 37 years of bacterial endocarditis [<xref ref-type="bibr" rid="g6pc3-def.REF.fernandez.2012.111">Fernandez et al 2012</xref>].</p>
          <p>Four deaths in the 14 individuals in the French Severe Congenital Neutropenia Registry were reported: one at age five years with sepsis, one at age 19 years from pulmonary insufficiency, and two from sudden death of unknown cause during sleep at age 30 years.</p>
        </sec>
        <sec id="g6pc3-def.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No obvious genotype-phenotype correlations explain the difference between the marked cellularity of myeloid cells in the bone marrow of patients with G6PC3 deficiency [<xref ref-type="bibr" rid="g6pc3-def.REF.banka.2011b.235">Banka et al 2011b</xref>].</p>
          <p>Based on limited data certain pathogenic variants (e.g., p.Phe44Ser) appear to be more often (or only) associated with nonsyndromic neutropenia [<xref ref-type="bibr" rid="g6pc3-def.REF.banka.2013.138">Banka et al 2013</xref>].</p>
        </sec>
        <sec id="g6pc3-def.Prevalence">
          <title>Prevalence</title>
          <p>To date more than 91 individuals with the molecularly proven diagnosis of G6PC3 deficiency have been reported [<xref ref-type="bibr" rid="g6pc3-def.REF.alangari.2013.1403">Alangari et al 2013</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.banka.2013.84">Banka &#x00026; Newman 2013</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.est_vez.2013.e29">Est&#x000e9;vez et al 2013</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.racek.2013">Racek et al 2013</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.desplantes.2014.183">Desplantes et al 2014</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.kaya.2014.e316">Kaya et al 2014</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.notarangelo.2014.80">Notarangelo et al 2014</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.ozg_l.2014.265">Ozg&#x000fc;l et al 2014</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.tavil.2014.426">Tavil et al 2014</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.yeshayahu.2014.197">Yeshayahu et al 2014</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.arikoglu.2015.79">Arikoglu et al 2015</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.lebel.2015.103">Lebel et al 2015</xref>].</p>
          <p>The prevalence is likely to vary significantly from population to population based on the presence of founder variants in certain populations [<xref ref-type="bibr" rid="g6pc3-def.REF.smith.2012.146">Smith et al 2012</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.banka.2013.84">Banka &#x00026; Newman 2013</xref>] and cultural practices such as consanguinity. For example, G6PC3 deficiency was found to be the most common cause of severe congenital neutropenia in Israel, accounting for the diagnosis in 25% of patients [<xref ref-type="bibr" rid="g6pc3-def.REF.lebel.2015.103">Lebel et al 2015</xref>].</p>
          <p>The French Neutropenia Registry has estimated incidence at birth at 0.4:1,000,000 [<xref ref-type="bibr" rid="g6pc3-def.REF.desplantes.2014.183">Desplantes et al 2014</xref>].</p>
        </sec>
      </sec>
      <sec id="g6pc3-def.Genetically_Related_Allelic_Di">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">G6PC3</italic>.</p>
      </sec>
      <sec id="g6pc3-def.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Severe congenital neutropenia is genetically heterogeneous [<xref ref-type="bibr" rid="g6pc3-def.REF.klein.2009.1333">Klein 2009</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.donadieu.2011.26">Donadieu et al 2011</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.klein.2011.399">Klein 2011</xref>]. The differential diagnosis of G6PC3 deficiency can be divided into inherited conditions in which neutropenia predominates and those in which neutropenia may be a part of a multi-system disorder.</p>
        <p>
          <bold>Inherited conditions in which neutropenia predominates</bold>
        </p>
        <p><related-object link-type="booklink" source-id="gene" document-id="cyclic-n" document-type="chapter"><bold>Severe congenital neutropenia type 1</bold></related-object>
<bold>(SCN1),</bold> an autosomal dominant disorder caused by mutation of <italic toggle="yes">ELANE</italic>, is the most common genetic cause of congenital neutropenia. <italic toggle="yes">ELANE</italic>-related congenital neutropenia is characterized by recurrent fever, skin and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis), and cervical adenopathy [<xref ref-type="bibr" rid="g6pc3-def.REF.dale.2000.2317">Dale et al 2000</xref>]. Mutation of <italic toggle="yes">ELANE</italic> also causes cyclic neutropenia, a less severe disorder.</p>
        <p><bold>Severe congenital neutropenia type 2 (SCN2)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/613107">613107</ext-link>), an autosomal dominant disorder caused by mutation of <italic toggle="yes">GFI1,</italic> is characterized by an increased susceptibility to bacterial infections [<xref ref-type="bibr" rid="g6pc3-def.REF.person.2003.308">Person et al 2003</xref>]. Mutation of <italic toggle="yes">GFI1</italic> also causes chronic non-autoimmune neutropenia which manifests as monocytosis in adults.</p>
        <p><bold>Kostmann disease (severe congenital neutropenia type 3)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/610738">610738</ext-link>), an autosomal recessive disorder caused by mutation of <italic toggle="yes">HAX1,</italic> is characterized by neutropenia, maturation arrest of the promyelocyte or myelocyte stage with or without seizures, and developmental delay [<xref ref-type="bibr" rid="g6pc3-def.REF.klein.2007.86">Klein et al 2007</xref>].</p>
        <p><bold>Severe congenital neutropenia type 5 (SCN5)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/615285">615285</ext-link>), an autosomal recessive disorder caused by mutation of <italic toggle="yes">VPS45,</italic> is characterized by neutropenia, neutrophil dysfunction, bone marrow fibrosis, and nephromegaly resulting from renal extramedullary hematopoiesis [<xref ref-type="bibr" rid="g6pc3-def.REF.vilboux.2013.54">Vilboux et al 2013</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="was" document-type="chapter"><bold>Severe congenital neutropenia, X-linked</bold></related-object>
<bold>(XLN)</bold>, caused by mutation of <italic toggle="yes">WAS,</italic> is characterized in males by recurrent bacterial infections, persistent neutropenia, and arrested development of the bone marrow at the promyelocyte/myelocyte stage in the absence of other clinical findings of Wiskott-Aldrich syndrome.</p>
        <p><bold><italic toggle="yes">JAGN1</italic>-related severe congenital neutropenia (severe congenital neutropenia type 6)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/616022">616022</ext-link>), an autosomal recessive disorder, is characterized by severe congenital neutropenia, increased susceptibility to bacterial infections, maturation arrest at the promyelocyte/myelocyte stage in the bone marrow, and poor response to treatment with human granulocyte colony-stimulating factor (rhG-CSF) [<xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2014.1021">Boztug et al 2014</xref>]. Occasionally abnormalities are observed in bone, pancreas, and/or teeth.</p>
        <p>
          <bold>Inherited conditions in which neutropenia may be part of a multi-system disorder</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="barth" document-type="chapter">Barth syndrome</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="chh" document-type="chapter">Cartilage-hair hypoplasia</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="cmt-dib" document-type="chapter">Charcot-Marie-Tooth disease caused by mutation of <italic toggle="yes">DNM2</italic></related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="chediak-higashi" document-type="chapter">Chediak-Higashi syndrome</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Clericuzio poikiloderma with neutropenia (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/604173">604173</ext-link>)</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="cohen" document-type="chapter">Cohen syndrome</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="gsd1" document-type="chapter">Glycogen storage disease type 1b</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Griscelli syndrome type 2 (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/607624">607624</ext-link>)</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="hps" document-type="chapter">Hermansky-Pudlak syndrome type 2</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Immunodeficiency due to defect in MAPBP-interacting protein (P14 deficiency) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/610798">610798</ext-link>)</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="kss" document-type="chapter">Pearson syndrome</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="sds" document-type="chapter">Shwachman-Diamond syndrome</related-object>
            </p>
          </list-item>
          <list-item>
            <p>WHIM syndrome (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/193670">193670</ext-link>)</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="was" document-type="chapter">Wiskott-Aldrich syndrome</related-object>
            </p>
          </list-item>
        </list>
      </sec>
      <sec id="g6pc3-def.Management">
        <title>Management</title>
        <sec id="g6pc3-def.Evaluations_Following_Initial">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with G6PC3 deficiency, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Full blood count to look for evidence of other hematologic involvement (i.e., intermittent thrombocytopenia and/or lymphopenia)</p>
            </list-item>
            <list-item>
              <p>Immunologic evaluation for T-cell subsets in individuals with a more severe presentation and unusual non-bacterial infections</p>
            </list-item>
            <list-item>
              <p>Consultation with a cardiologist to evaluate for congenital heart disease</p>
            </list-item>
            <list-item>
              <p>Renal and pelvic ultrasound examination to look for urogenital malformations</p>
            </list-item>
            <list-item>
              <p>Growth parameters in children and pubertal development in adolescents</p>
            </list-item>
            <list-item>
              <p>Age appropriate endocrine assessment for evidence of the hormone deficiencies reported (i.e., growth hormone, gonadotropins, thyroid hormone)</p>
            </list-item>
            <list-item>
              <p>Biochemical investigations to look for abnormalities in the lipid profile</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="g6pc3-def.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Neutropenia</bold>. Treatment with granulocyte colony stimulating factor (G-CSF) improves neutrophil numbers, reduces the number of infections, and improves the quality of life [<xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2009.32">Boztug et al 2009</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.mcdermott.2010.2793">McDermott et al 2010</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2012.679">Boztug et al 2012</xref>]. Of note, the dose required to keep absolute neutrophil counts above 0.5x10<sup>9</sup>/L can vary greatly among patients. In some patients G-CSF -- even in large doses -- may fail to control infections [<xref ref-type="bibr" rid="g6pc3-def.REF.smith.2012.146">Smith et al 2012</xref>].</p>
          <p>A few mildly affected individuals have been reported to be adequately managed with prophylactic antibiotics alone [<xref ref-type="bibr" rid="g6pc3-def.REF.banka.2013.138">Banka et al 2013</xref>]. However, prophylactic antibiotics have a limited use for preventing severe infections or bronchiectasis and inflammatory bowel disease.</p>
          <p>Fevers and infections require prompt treatment with antibiotics.</p>
          <p>
            <bold>Other</bold>
          </p>
        </sec>
        <sec id="g6pc3-def.Prevention_of_Secondary_Compli">
          <title>Prevention of Secondary Complications</title>
          <p>Good dental hygiene, including careful brushing and flossing and regular visits to the dentist, helps decrease the potential for infection. Prophylactic antibiotics should be considered with dental procedures, including routine dental repair and cleaning, especially in individuals with heart defects.</p>
        </sec>
        <sec id="g6pc3-def.Surveillance">
          <title>Surveillance</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Routine management of congenital heart disease, renal and urinary tract malformations</p>
            </list-item>
            <list-item>
              <p>Routine management of hormone deficiencies</p>
            </list-item>
            <list-item>
              <p>Consideration of oral steroids for inflammatory bowel disease [<xref ref-type="bibr" rid="g6pc3-def.REF.desplantes.2014.183">Desplantes et al 2014</xref>] or anti-TNF treatment [<xref ref-type="bibr" rid="g6pc3-def.REF.b_gin.2013.520">B&#x000e9;gin et al 2013</xref>]. Some complications of IBD such as bowel stenosis may require appropriate surgical intervention.</p>
            </list-item>
            <list-item>
              <p>Consideration of pancreatic enzyme supplementation if steatorrhea is present [<xref ref-type="bibr" rid="g6pc3-def.REF.desplantes.2014.183">Desplantes et al 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>Chemotherapy and hematopoietic stem cell transplantation for acute myelogeneous leukemia</p>
            </list-item>
            <list-item>
              <p>Frequent follow up by a hematologist or immunologist to monitor infection frequency and neutrophil counts to ensure an adequate response to G-CSF (i.e., absolute neutrophil counts above 0.5x109/L)</p>
            </list-item>
            <list-item>
              <p>Monitoring of growth in children and pubertal development in adolescents</p>
            </list-item>
            <list-item>
              <p>Biochemical profile including lipid profile</p>
            </list-item>
            <list-item>
              <p>Monitoring for development of varicose veins, especially in adults</p>
            </list-item>
            <list-item>
              <p>Monitoring for osteopenia/osteoporosis</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">G6PC3</italic> pathogenic variants in the family are known, molecular genetic testing can be used to clarify the genetic status of at-risk sibs.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">G6PC3</italic> pathogenic variants in the family are not known, the following evaluations can be used to help clarify the disease status of at-risk sibs: full blood count, bone marrow examination (if persistent severe neutropenia is detected on full blood count), directed general examination for prominence of superficial veins, echocardiogram, and a renal and pelvic ultrasound examination.</p>
            </list-item>
          </list>
        </sec>
        <sec id="g6pc3-def.Evaluation_of_Relatives_at_Ris">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate the older and younger sibs of a proband in order to identify as early as possible those who would benefit from early diagnosis and management of the hematologic, cardiac, renal, and endocrine abnormalities of G6PC3 deficiency.</p>
          <p>See <xref ref-type="sec" rid="g6pc3-def.Related_Genetic_Counseling_Iss">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="g6pc3-def.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="g6pc3-def.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="g6pc3-def.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>G6PC3 deficiency is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="g6pc3-def.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">G6PC3</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier of a <italic toggle="yes">G6PC3</italic> pathogenic variant is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with G6PC3 deficiency are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">G6PC3</italic>.</p>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of a <italic toggle="yes">G6PC3</italic> pathogenic variant.</p>
        </sec>
        <sec id="g6pc3-def.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">G6PC3</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="g6pc3-def.Related_Genetic_Counseling_Iss">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="g6pc3-def.Evaluation_of_Relatives_at_Ris">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="g6pc3-def.Prenatal_Testing_and_Preimplan">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">G6PC3</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for G6PC3 deficiency are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="g6pc3-def.Resources">
        <title>Resources</title>
      </sec>
      <sec id="g6pc3-def.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="g6pc3-def.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>G6PC3 deficiency causes decreased cytoplasmic glucose and glucose-6-phosphate levels [<xref ref-type="bibr" rid="g6pc3-def.REF.jun.2012.4047">Jun et al 2012</xref>] that lead to activation of GSK-3&#x003b2; and phosphorylation-mediated inactivation of the anti-apoptotic molecule Mcl-1. Activation of the endoplasmic reticulum stress mechanism and increased susceptibility to cellular apoptosis has been demonstrated [<xref ref-type="bibr" rid="g6pc3-def.REF.boztug.2009.32">Boztug et al 2009</xref>, <xref ref-type="bibr" rid="g6pc3-def.REF.jun.2011.3881">Jun et al 2011</xref>]. G6PC3 deficiency also results in aberrant glycosylation of a NADPH oxidase subunit, gp91phox leading to deficits in neutrophil function.</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">G6PC3</italic> consists of six exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="g6pc3-def" object-id="g6pc3-def.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic variants.</bold>
<italic toggle="yes">G6PC3</italic> pathogenic variants include missense, nonsense, and splice-site variants and frameshift deletions or insertions. Pathogenic missense variants generally lead to non-conservative substitutions at highly conserved residues.</p>
          <p>A number of founder variants have been identified, including:</p>
          <list list-type="bullet">
            <list-item>
              <p>p.Phe44Ser in individuals of Pakistani origin [<xref ref-type="bibr" rid="g6pc3-def.REF.smith.2012.146">Smith et al 2012</xref>];</p>
            </list-item>
            <list-item>
              <p>p.Arg253His in individuals from diverse backgrounds in the Middle East [<xref ref-type="bibr" rid="g6pc3-def.REF.banka.2011a.18">Banka et al 2011a</xref>];</p>
            </list-item>
            <list-item>
              <p>p.Gly260Arg in individuals with European ancestry [<xref ref-type="bibr" rid="g6pc3-def.REF.banka.2013.84">Banka &#x00026; Newman 2013</xref>].</p>
            </list-item>
          </list>
          <p>Other pathogenic variants detected in two or more unrelated individuals of the same ancestry include p.Phe71SerfsTer46 (&#x0201c;Hispanic&#x0201d;), p.Gly277Ter (European), and p.Asn313GlnfsTer74 (Iranian) [<xref ref-type="bibr" rid="g6pc3-def.REF.banka.2013.84">Banka &#x00026; Newman 2013</xref>].</p>
          <table-wrap id="g6pc3-def.T.g6pc3_pathogenic_variants_di" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p><italic toggle="yes">G6PC3</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_g6pc3-def.T.g6pc3_pathogenic_variants_di_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_g6pc3-def.T.g6pc3_pathogenic_variants_di_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change <break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_h_g6pc3-def.T.g6pc3_pathogenic_variants_di_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_g6pc3-def.T.g6pc3_pathogenic_variants_di_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.130C&#x0003e;T</td>
                  <td headers="hd_h_g6pc3-def.T.g6pc3_pathogenic_variants_di_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe44Ser</td>
                  <td headers="hd_h_g6pc3-def.T.g6pc3_pathogenic_variants_di_1_1_1_3" rowspan="6" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_138387.3">NM_138387.3</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_612396.1">NP_612396.1</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_g6pc3-def.T.g6pc3_pathogenic_variants_di_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.210delC</td>
                  <td headers="hd_h_g6pc3-def.T.g6pc3_pathogenic_variants_di_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe71SerfsTer46<break/>(Ile70fsTer46)</td>
                </tr>
                <tr>
                  <td headers="hd_h_g6pc3-def.T.g6pc3_pathogenic_variants_di_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.758G&#x0003e;A</td>
                  <td headers="hd_h_g6pc3-def.T.g6pc3_pathogenic_variants_di_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg253His</td>
                </tr>
                <tr>
                  <td headers="hd_h_g6pc3-def.T.g6pc3_pathogenic_variants_di_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.778G&#x0003e;C</td>
                  <td headers="hd_h_g6pc3-def.T.g6pc3_pathogenic_variants_di_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly260Arg</td>
                </tr>
                <tr>
                  <td headers="hd_h_g6pc3-def.T.g6pc3_pathogenic_variants_di_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.829C&#x0003e;T</td>
                  <td headers="hd_h_g6pc3-def.T.g6pc3_pathogenic_variants_di_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly277Ter</td>
                </tr>
                <tr>
                  <td headers="hd_h_g6pc3-def.T.g6pc3_pathogenic_variants_di_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.935dupT</td>
                  <td headers="hd_h_g6pc3-def.T.g6pc3_pathogenic_variants_di_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn313GlnfsTer74<break/>(Asn313fs)</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="g6pc3-def.TF.2.1">
                <label>1. </label>
                <p>Variant designation that does not conform to current naming conventions</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> G6PC3 is found in the endoplasmic reticulum and comprises 346 amino acid residues. The signature phosphatase motif is between residues 66 and 171.</p>
          <p><bold>Abnormal gene product.</bold> It is predicted that missense variants destabilize the mutated protein and truncating variants lead to nonsense-mediated decay of the transcript or the generation of abnormal gene product [<xref ref-type="bibr" rid="g6pc3-def.REF.banka.2013.84">Banka &#x00026; Newman 2013</xref>].</p>
        </sec>
      </sec>
      <sec id="g6pc3-def.References">
        <title>References</title>
        <sec id="g6pc3-def.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="g6pc3-def.Literature_Cited.reflist0">
            <ref id="g6pc3-def.REF.alangari.2013.1403">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alangari</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alsultan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osman</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anazi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alkuraya</surname>
                    <given-names>FS</given-names>
                  </name>
                </person-group>
                <article-title>A Novel Homozygous Mutation in G6PC3 Presenting as Cyclic Neutropenia and Severe Congenital Neutropenia in the Same Family.</article-title>
                <source>J Clin Immunol.</source>
                <year>2013</year>
                <volume>33</volume>
                <fpage>1403</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">24105461</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.alizadeh.2011.227">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alizadeh</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fazlollahi</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eshghi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamidieh</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghadami</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pourpak</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <article-title>Two cases of syndromic neutropenia with a report of novel mutation in G6PC3.</article-title>
                <source>Iran J Allergy Asthma Immunol.</source>
                <year>2011</year>
                <volume>10</volume>
                <fpage>227</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">21891829</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.arikoglu.2015.79">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arikoglu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuyucu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Germeshausen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuyucu</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Author information A novel G6PC3 gene mutation in severe congenital neutropenia: pancytopenia and variable bone marrow phenotype can also be part of this syndrome.</article-title>
                <source>Eur J Haematol.</source>
                <year>2015</year>
                <volume>94</volume>
                <fpage>79</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">24750412</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.aytekin.2013.e81">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aytekin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Germeshausen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuygun</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dogu</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikinciogullari</surname>
                    <given-names>A. A</given-names>
                  </name>
                </person-group>
                <article-title>Novel G6PC3 Gene Mutation in a Patient With Severe Congenital Neutropenia.</article-title>
                <source>J. Pediatr Hematol Oncol.</source>
                <year>2013</year>
                <volume>35</volume>
                <fpage>e81</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">23018568</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.banka.2011a.18">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Banka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chervinsky</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crow</surname>
                    <given-names>YJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yeganeh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yacobovich</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donnai</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shalev</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Further delineation of the phenotype of severe congenital neutropenia type 4 due to mutations in G6PC3.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2011a</year>
                <volume>19</volume>
                <fpage>18</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">20717171</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.banka.2010.2609">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Banka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>&#x000d6;zg&#x000fc;l</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dursun</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the G6PC3 gene cause Dursun syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2010</year>
                <volume>152A</volume>
                <fpage>2609</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">20799326</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.banka.2013.84">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Banka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>WG</given-names>
                  </name>
                </person-group>
                <article-title>A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3 mutations.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2013</year>
                <volume>8</volume>
                <fpage>84</fpage>
                <pub-id pub-id-type="pmid">23758768</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.banka.2013.138">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Banka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wynn</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Byers</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arkwright</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>WG</given-names>
                  </name>
                </person-group>
                <article-title>G6PC3 mutations cause non-syndromic severe congenital neutropenia.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2013</year>
                <volume>108</volume>
                <fpage>138</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">23298686</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.banka.2011b.235">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Banka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wynn</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>WG</given-names>
                  </name>
                </person-group>
                <article-title>Variability of bone marrow morphology in G6PC3 mutations: Is there a genotype-phenotype correlation or age-dependent relationship?</article-title>
                <source>Am J Hematol.</source>
                <year>2011b</year>
                <volume>86</volume>
                <fpage>235</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21264919</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.b_gin.2013.520">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>B&#x000e9;gin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patey</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mueller</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasquin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sirard</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haddad</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drouin</surname>
                    <given-names>&#x000c9;</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Deist</surname>
                    <given-names>F.</given-names>
                  </name>
                </person-group>
                <article-title>Inflammatory bowel disease and T cell lymphopenia in G6PC3 deficiency.</article-title>
                <source>J Clin Immunol.</source>
                <year>2013</year>
                <volume>33</volume>
                <fpage>520</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">23180359</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.boztug.2009.32">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boztug</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appaswamy</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashikov</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000e4;ffer</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salzer</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diestelhorst</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Germeshausen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandes</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee-Gossler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noyan</surname>
                    <given-names>F</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>a syndrome with congenital neutropenia and mutations in G6PC3.</article-title>
                <source>N Engl J Med.</source>
                <year>2009</year>
                <volume>360</volume>
                <fpage>32</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">19118303</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.boztug.2014.1021">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boztug</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000e4;rvinen</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salzer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Racek</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000f6;nch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garncarz</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gertz</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000e4;ffer</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antonopoulos</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haslam</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schieck</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pucha&#x00142;ka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diestelhorst</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appaswamy</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lescoeur</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giambruno</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bigenzahn</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elling</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfeifer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conde</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albert</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welte</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandes</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sherkat</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Werff ten Bosch</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rezaei</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Etzioni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellann&#x000e9;-Chantelot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penninger</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Blume</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donadieu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>JAGN1 deficiency causes aberrant myeloid cell homeostasis and congenital neutropenia.</article-title>
                <source>Nat Genet.</source>
                <year>2014</year>
                <volume>46</volume>
                <fpage>1021</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">25129144</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.boztug.2012.679">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boztug</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moulton</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curtin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rezaei</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corns</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Innis</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avci</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tran</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellier</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierani</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fruge</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parvaneh</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mamishi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mody</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darbyshire</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Motwani</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchanan</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alter</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boxer</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donadieu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welte</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: novel genotypes and phenotypic variability in severe congenital neutropenia.</article-title>
                <source>J Pediatr.</source>
                <year>2012</year>
                <volume>160</volume>
                <fpage>679</fpage>
                <lpage>683.e2</lpage>
                <pub-id pub-id-type="pmid">22050868</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.cullinane.2011.2017">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cullinane</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilboux</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O&#x02019;Brien</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curry</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maynard</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carlson-Donohoe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciccone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markello</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunay-Aygun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huizing</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <article-title>Homozygosity mapping and whole-exome sequencing to detect SLC45A2 and G6PC3 mutations in a single patient with oculocutaneous albinism and neutropenia.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2011</year>
                <volume>131</volume>
                <fpage>2017</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">21677667</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.dale.2000.2317">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dale</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Person</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolyard</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aprikyan</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boxer</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kannourakis</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeidler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welte</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benson</surname>
                    <given-names>KF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horwitz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia.</article-title>
                <source>Blood.</source>
                <year>2000</year>
                <volume>96</volume>
                <fpage>2317</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">11001877</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.desplantes.2014.183">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Desplantes</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fremond</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beaupain</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harousseau</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buzyn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellier</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roques</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morville</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paillard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruneau</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeziorski</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vannier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Picard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellanger</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Pontual</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lapillonne</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lutz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chantelot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donadieu</surname>
                    <given-names>J.</given-names>
                  </name>
                </person-group>
                <article-title>Clinical spectrum and long-term follow-up of 14 cases with G6PC3 mutations from the French severe congenital neutropenia registry.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2014</year>
                <volume>9</volume>
                <fpage>183</fpage>
                <pub-id pub-id-type="pmid">25491320</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.donadieu.2011.26">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Donadieu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fenneteau</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beaupain</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahlaoui</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellanne Chantelot</surname>
                    <given-names>C.</given-names>
                  </name>
                </person-group>
                <article-title>Congenital neutropenia: diagnosis, molecular bases and patient management.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2011</year>
                <volume>6</volume>
                <fpage>26</fpage>
                <pub-id pub-id-type="pmid">21595885</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.dursun.2009.19">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dursun</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozgul</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soydas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tugrul</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurgey</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Celiker</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barst</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knowles</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahesh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morse</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <article-title>Familial pulmonary arterial hypertension, leucopenia, and atrial septal defect: a probable new familial syndrome with multisystem involvement.</article-title>
                <source>Clin Dysmorphol.</source>
                <year>2009</year>
                <volume>18</volume>
                <fpage>19</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">19011569</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.est_vez.2013.e29">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Est&#x000e9;vez</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ortega</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tejero</surname>
                    <given-names>&#x000c1;</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fern&#x000e1;ndez</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aguado</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ar&#x000f3;stegui</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez-Roca</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pe&#x000f1;a</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santamar&#x000ed;a</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>A novel phenotype variant of severe congenital neutropenia caused by G6PC3 deficiency.</article-title>
                <source>Pediatr Blood Cancer.</source>
                <year>2013</year>
                <volume>60</volume>
                <fpage>E29</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">23441086</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.fernandez.2012.111">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fernandez</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bursey</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrett</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacMillan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McColl</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahoney</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pereira</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherer</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boycott</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woods</surname>
                    <given-names>MO</given-names>
                  </name>
                </person-group>
                <article-title>Adult siblings with homozygous G6PC3 mutations expand our understanding of the severe congenital neutropenia type 4 (SCN4) phenotype.</article-title>
                <source>BMC Med Genet.</source>
                <year>2012</year>
                <volume>13</volume>
                <fpage>111</fpage>
                <pub-id pub-id-type="pmid">23171239</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.gatti.2011.138">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gatti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boztug</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasqualini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albano</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierani</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>A Case of syndromic neutropenia and mutation in G6PC3.</article-title>
                <source>J Pediatr Hematol Oncol.</source>
                <year>2011</year>
                <volume>33</volume>
                <fpage>138</fpage>
                <pub-id pub-id-type="pmid">21285905</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.germeshausen.2010.1207">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Germeshausen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeidler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stuhrmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanciotti</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballmaier</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welte</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Digenic mutations in severe congenital neutropenia.</article-title>
                <source>Haematologica.</source>
                <year>2010</year>
                <volume>95</volume>
                <fpage>1207</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">20220065</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.jun.2012.4047">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jun</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheung</surname>
                    <given-names>YY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>YM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mansfield</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chou</surname>
                    <given-names>JY</given-names>
                  </name>
                </person-group>
                <article-title>Glucose-6-phosphatase-&#x003b2;, implicated in a congenital neutropenia syndrome, is essential for macrophage energy homeostasis and functionality.</article-title>
                <source>Blood.</source>
                <year>2012</year>
                <volume>119</volume>
                <fpage>4047</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">22246029</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.jun.2011.3881">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jun</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>YM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mansfield</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chou</surname>
                    <given-names>JY</given-names>
                  </name>
                </person-group>
                <article-title>G-CSF improves murine G6PC3-deficient neutrophil function by modulating apoptosis and energy homeostasis.</article-title>
                <source>Blood</source>
                <year>2011</year>
                <volume>117</volume>
                <fpage>3881</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">21292774</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.kaya.2014.e316">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaya</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>E&#x0011f;rita&#x0015f;</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albayrak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000f6;&#x000e7;&#x000fc;n</surname>
                    <given-names>PU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ko&#x000e7;ak</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalgi&#x000e7;</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000fc;rsel</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Resolution of inflammatory colitis with pegfilgrastim treatment in a case of severe congenital neutropenia due to glucose 6 phosphatase catalytic subunit-3 deficiency.</article-title>
                <source>J Pediatr Hematol Oncol.</source>
                <year>2014</year>
                <volume>36</volume>
                <fpage>e316</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">24322501</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.klein.2007.86">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grudzien</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appaswamy</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Germeshausen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandrock</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaffer</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rathinam</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boztug</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwinzer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rezaei</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohn</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carlsson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fadeel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahl</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmblad</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henter</surname>
                    <given-names>J-I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeidler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimbacher</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welte</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease).</article-title>
                <source>Nat Genet.</source>
                <year>2007</year>
                <volume>39</volume>
                <fpage>86</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">17187068</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.klein.2011.399">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C.</given-names>
                  </name>
                </person-group>
                <article-title>Genetic defects in severe congenital neutropenia: emerging insights into life and death of human neutrophil granulocytes.</article-title>
                <source>Annu Rev Immunol.</source>
                <year>2011</year>
                <volume>29</volume>
                <fpage>399</fpage>
                <lpage>413</lpage>
                <pub-id pub-id-type="pmid">21219176</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.klein.2009.1333">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C.</given-names>
                  </name>
                </person-group>
                <article-title>Molecular basis of congenital neutropenia.</article-title>
                <source>Haematologica.</source>
                <year>2009</year>
                <volume>94</volume>
                <fpage>1333</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19794077</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.lebel.2015.103">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lebel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yacobovich</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krasnov</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koren</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplinsky</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravel-Vilk</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laor</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attias</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barak</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shtager</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuperman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miskin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dgany</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giri</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alter</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamary</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Genetic analysis and clinical picture of severe congenital neutropenia in Israel.</article-title>
                <source>Pediatr Blood Cancer.</source>
                <year>2015</year>
                <volume>62</volume>
                <fpage>103</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">25284454</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.mcdermott.2010.2793">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McDermott</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Ravin</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jun</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priel</surname>
                    <given-names>DAL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takemoto</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ojode</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paul</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunsmore</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilligoss</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marquesen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ulrick</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhns</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chou</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>PM</given-names>
                  </name>
                </person-group>
                <article-title>Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis.</article-title>
                <source>Blood</source>
                <year>2010</year>
                <volume>116</volume>
                <fpage>2793</fpage>
                <lpage>802</lpage>
                <pub-id pub-id-type="pmid">20616219</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.notarangelo.2014.80">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Notarangelo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savoldi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavagnini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennato</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasile</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pilotta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plebani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porta</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Severe congenital neutropenia due to G6PC3 deficiency: early and delayed phenotype in two patients with two novel mutations.</article-title>
                <source>Ital J Pediatr.</source>
                <year>2014</year>
                <volume>40</volume>
                <fpage>80</fpage>
                <pub-id pub-id-type="pmid">25391451</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.ozg_l.2014.265">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ozg&#x000fc;l</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Y&#x000fc;cel-Y&#x00131;lmaz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dursun</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Dursun Syndrome Due to G6PC3 Gene Defect has a Fluctuating Pattern in All Blood Cell Lines.</article-title>
                <source>J Clin Immunol.</source>
                <year>2014</year>
                <volume>34</volume>
                <fpage>265</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">24549407</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.person.2003.308">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Person</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>F-Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duan</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benson</surname>
                    <given-names>KF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wechsler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papadaki</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eliopoulos</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufman</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertolone</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamoto</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papayannopoulou</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimes</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horwitz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2.</article-title>
                <source>Nat Genet.</source>
                <year>2003</year>
                <volume>34</volume>
                <fpage>308</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">12778173</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.racek.2013">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Racek</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puchalka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohistani</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C.</given-names>
                  </name>
                </person-group>
                <article-title>Novel NGS-based platforms for molecular diagnosis of severe congenital neutropenia.</article-title>
                <source>Blood.</source>
                <year>2013</year>
                <volume>122</volume>
                <issue>21</issue>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.smith.2012.146">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>BN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ali</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ancliff</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayee</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Segal</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaya</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shakoori</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linch</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gale</surname>
                    <given-names>RE</given-names>
                  </name>
                </person-group>
                <article-title>Phenotypic heterogeneity and evidence of a founder effect associated with G6PC3 mutations in patients with severe congenital neutropenia.</article-title>
                <source>Br J Haematol.</source>
                <year>2012</year>
                <volume>158</volume>
                <fpage>146</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22469094</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.tavil.2014.426">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tavil</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gumruk</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Sea-blue histiocytes in the bone marrow of a boy with severe congenital neutropenia associated with G6PC3 mutation.</article-title>
                <source>Br J Haematol.</source>
                <year>2014</year>
                <volume>165</volume>
                <fpage>426</fpage>
                <pub-id pub-id-type="pmid">24446813</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.vilboux.2013.54">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vilboux</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lev</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malicdan</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simon</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000e4;rvinen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Racek</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puchalka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sood</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrington</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bishop</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullikin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huizing</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garty</surname>
                    <given-names>BZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eyal</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolach</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gavrieli</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toren</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soudack</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atawneh</surname>
                    <given-names>OM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babushkin</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiby</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cullinane</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avivi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polak-Charcon</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barshack</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amariglio</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rechavi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Werff ten Bosch</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anikster</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somech</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>A congenital neutrophil defect syndrome associated with mutations in VPS45.</article-title>
                <source>N Engl J Med.</source>
                <year>2013</year>
                <volume>369</volume>
                <fpage>54</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">23738510</pub-id>
              </element-citation>
            </ref>
            <ref id="g6pc3-def.REF.yeshayahu.2014.197">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yeshayahu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asaf</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubnov-Raz</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiby</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simon</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lev</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somech</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Testicular failure in a patient with G6PC3 deficiency.</article-title>
                <source>Pediatr Res.</source>
                <year>2014</year>
                <volume>76</volume>
                <fpage>197</fpage>
                <lpage>201</lpage>
                <pub-id pub-id-type="pmid">24796372</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="g6pc3-def.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="g6pc3-def.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>16 April 2015 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>10 September 2014 (sb) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
